Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Argus Health
Moodys
US Department of Justice
US Army
Chubb
Fish and Richardson
Johnson and Johnson
Federal Trade Commission
Daiichi Sankyo

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020549

« Back to Dashboard

NDA 020549 describes FLOVENT, which is a drug marketed by Glaxosmithkline and Glaxo Grp Ltd and is included in four NDAs. There are fifteen patents protecting this drug. Additional details are available on the FLOVENT profile page.

The generic ingredient in FLOVENT is fluticasone propionate. There are twenty-six drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 020549
Tradename:FLOVENT
Applicant:Glaxosmithkline
Ingredient:fluticasone propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INHALATIONStrength0.044MG/INH
Approval Date:Nov 7, 1997TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INHALATIONStrength0.088MG/INH
Approval Date:Nov 7, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INHALATIONStrength0.22MG/INH
Approval Date:Nov 7, 1997TE:RLD:No

Expired US Patents for NDA 020549

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline FLOVENT fluticasone propionate POWDER;INHALATION 020549-001 Nov 7, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline FLOVENT fluticasone propionate POWDER;INHALATION 020549-002 Nov 7, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline FLOVENT fluticasone propionate POWDER;INHALATION 020549-003 Nov 7, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Army
Cerilliant
McKesson
Moodys
Express Scripts
Daiichi Sankyo
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot